Medtronic slips as FDA panel snubs blood pressure device

@MentallyGone – MDT thought that Covid resulted in new medications prescribed for the pool of high blood pressure patients in the study population and affected the results. High blood pressure was a key “co-morbidity” factor in determining the severity of Covid contracted by at-risk patients. Drugs like Ivermectin and others were being prescribed. The FDA panel was split on it and the Chairman had to break the tie. My thought was why didn’t they start over? I hope that comes up. It may be that FDA procedures or a ruling determined how it was handled. It may work well enough to try before a surgical solution.